======= TIMP3 ======= == Gene Information == * **Official Symbol**: TIMP3 * **Official Name**: TIMP metallopeptidase inhibitor 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7078|7078]] * **UniProt**: [[https://www.uniprot.org/uniprot/P35625|P35625]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TIMP3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TIMP3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/188826|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene belongs to the TIMP gene family. The proteins encoded by this gene family are inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix (ECM). Expression of this gene is induced in response to mitogenic stimulation and this netrin domain-containing protein is localized to the ECM. Mutations in this gene have been associated with the autosomal dominant disorder Sorsby's fundus dystrophy. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Complexes with metalloproteinases (such as collagenases) and irreversibly inactivates them by binding to their catalytic zinc cofactor. May form part of a tissue-specific acute response to remodeling stimuli. Known to act on MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, MMP-13, MMP-14 and MMP-15. |TIMP| |positive regulation of TRAIL-activated apoptotic signaling pathway| |regulation of TRAIL-activated apoptotic signaling pathway| |negative regulation of metalloendopeptidase activity| |negative regulation of metallopeptidase activity| |regulation of metalloendopeptidase activity| |negative regulation of membrane protein ectodomain proteolysis| |regulation of metallopeptidase activity| |platelet dense granule lumen| |positive regulation of extrinsic apoptotic signaling pathway via death domain receptors| |metalloendopeptidase inhibitor activity| |regulation of membrane protein ectodomain proteolysis| |positive regulation of extrinsic apoptotic signaling pathway| |regulation of extrinsic apoptotic signaling pathway via death domain receptors| |negative regulation of ERK1 and ERK2 cascade| |basement membrane| |protease binding| |platelet degranulation| |negative regulation of protein catabolic process| |regulation of extrinsic apoptotic signaling pathway| |negative regulation of MAPK cascade| |positive regulation of apoptotic signaling pathway| |visual perception| |sensory perception of light stimulus| |extracellular matrix| |negative regulation of endopeptidase activity| |negative regulation of cellular catabolic process| |negative regulation of peptidase activity| |regulation of ERK1 and ERK2 cascade| |negative regulation of catabolic process| |negative regulation of proteolysis| |collagen-containing extracellular matrix| |regulation of protein catabolic process| |regulation of apoptotic signaling pathway| |negative regulation of protein phosphorylation| |regulation of endopeptidase activity| |negative regulation of phosphorylation| |regulation of peptidase activity| |negative regulation of hydrolase activity| |negative regulation of intracellular signal transduction| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of protein modification process| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |positive regulation of cell death| |regulated exocytosis| |regulation of proteolysis| |regulation of MAPK cascade| |negative regulation of catalytic activity| |exocytosis| |regulation of cellular catabolic process| |response to hormone| |sensory perception| |regulation of catabolic process| |secretion by cell| |negative regulation of cellular protein metabolic process| |export from cell| |response to cytokine| |negative regulation of protein metabolic process| |secretion| |negative regulation of molecular function| |negative regulation of signal transduction| |regulation of hydrolase activity| |negative regulation of cell communication| |negative regulation of signaling| |nervous system process| |regulation of protein phosphorylation| |response to endogenous stimulus| |regulation of apoptotic process| |regulation of programmed cell death| |regulation of phosphorylation| |extracellular space| |negative regulation of response to stimulus| |positive regulation of signal transduction| |regulation of cell death| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |extracellular region| |vesicle-mediated transport| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|-1.74| |[[:results:exp484|GSK-J5 1.5μM R08 exp484]]|1.75| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9656 * **Expression level (log2 read counts)**: -3.35 {{:chemogenomics:nalm6 dist.png?nolink |}}